Working… Menu

The DIEP-Flap as a Model of Ischemia-Reperfusion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00482469
Recruitment Status : Completed
First Posted : June 5, 2007
Last Update Posted : January 7, 2009
Information provided by:
Maastricht University Medical Center

Brief Summary:
It is our goal to study the mechanism of ischemia-reperfusion injury. Our DIEP-operation is actually a clinical model of ischemia-reperfusion. Ischemia-reperfusion injury has never been directly studied in a human, clinical model of autologous transplant.

Condition or disease

Layout table for study information
Study Type : Observational
Actual Enrollment : 45 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: The DIEP-Flap as a Model of Ischemia-Reperfusion
Study Start Date : April 2007
Actual Study Completion Date : November 2008

Biospecimen Retention:   Samples With DNA
Frozen tissue.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Clinical patients hospitalized for surgery.

Inclusion Criteria:

  • patient is undergoing a DIEP-breast reconstruction, unilateral as well as bilateral
  • is aged 18 years or older

Exclusion Criteria:

  • diabetes mellitus
  • diseases of the kidneys
  • diseases of the liver
  • patients who are taking immunosuppressants

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00482469

Layout table for location information
Department of Plastic and Reconstructive surgery, Maastricht University Hospital
Maastricht, Netherlands, P.O. Box 5800-6202 AZ
Sponsors and Collaborators
Maastricht University Medical Center
Layout table for investigator information
Study Chair: René R Van der Hulst, MD, PhD Maastricht University Hospital
Principal Investigator: Marieke GW Van den Heuvel, MD Maastricht University Hospital

Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Dr. R. van der Hulst, M.D., University Hospital Maastricht Identifier: NCT00482469     History of Changes
Other Study ID Numbers: MEC 07-2-004
First Posted: June 5, 2007    Key Record Dates
Last Update Posted: January 7, 2009
Last Verified: January 2009
Keywords provided by Maastricht University Medical Center:
Additional relevant MeSH terms:
Layout table for MeSH terms
Pathologic Processes